Rapid Dose Therapeutics to Settle Interest with Shares

Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.

Rapid Dose Therapeutics Corp. plans to issue common shares to settle accrued interest payments on its secured convertible notes and secured debt, using the last closing market price of their shares on the CSE as the issue price. The company completed its private placement financing in 2023, raising over $3 million and issuing both notes and warrants. Shareholders and a director’s holding company will receive shares as payment for interest, aligning with the company’s financing terms.

For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.